Jonathan Sporn is the founder of Gilgamesh Pharmaceuticals. Gilgamesh Pharmaceuticals has raised $66M, latest Series B $39M (2022). Biotech · New York, NY.
Jonathan Sporn is the founder of Gilgamesh Pharmaceuticals. Gilgamesh Pharmaceuticals operates in Biotech and is based in New York, NY. Gilgamesh Pharmaceuticals has raised $66M, latest Series B $39M (2022). Backers on record include Daniel Goldberg, Palo Santo Fund.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in New York — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library